BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24312514)

  • 21. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
    Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
    Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA RP11-59H7.3 promotes cell proliferation and invasion metastasis in colorectal cancer by miR-139-5p/NOTCH1 axis.
    Zhu X; Luo C; Bu F; Lin K; Zhu Z
    Aging (Albany NY); 2020 Jun; 12(12):11653-11666. PubMed ID: 32507766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expressions of c-KIT and DOG-1 in mucinous and nonmucinous colorectal carcinomas and relation to clinicopathologic features and prognosis.
    Foda AA; Mohamed MA
    Ann Diagn Pathol; 2015 Oct; 19(5):335-40. PubMed ID: 26272691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells.
    Liao W; Li G; You Y; Wan H; Wu Q; Wang C; Lv N
    Oncol Rep; 2018 Mar; 39(3):1063-1071. PubMed ID: 29286145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
    Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
    Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma.
    Cong Z; Wu H; Guo Z; Qin T; Xu Y; Jing H; Wang Y; Shen Y
    Tumour Biol; 2017 Jun; 39(6):1010428317708698. PubMed ID: 28618922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer.
    Arcaroli JJ; Tai WM; McWilliams R; Bagby S; Blatchford PJ; Varella-Garcia M; Purkey A; Quackenbush KS; Song EK; Pitts TM; Gao D; Lieu C; McManus M; Tan AC; Zheng X; Zhang Q; Ozeck M; Olson P; Jiang ZQ; Kopetz S; Jimeno A; Keysar S; Eckhardt G; Messersmith WA
    Int J Cancer; 2016 Jan; 138(1):195-205. PubMed ID: 26152787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological and prognostic implications of polo-like kinase 1 expression in colorectal cancer: A systematic review and meta-analysis.
    Ran Z; Chen W; Shang J; Li X; Nie Z; Yang J; Li N
    Gene; 2019 Dec; 721():144097. PubMed ID: 31493507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models.
    Sun Y; Yokoi K; Li H; Gao J; Hu L; Liu B; Chen K; Hamilton SR; Fan D; Sun B; Zhang W
    Clin Cancer Res; 2011 Jul; 17(13):4331-40. PubMed ID: 21622717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.
    Rubie C; Frick VO; Pfeil S; Wagner M; Kollmar O; Kopp B; Graber S; Rau BM; Schilling MK
    World J Gastroenterol; 2007 Oct; 13(37):4996-5002. PubMed ID: 17854143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.
    Masuda S
    Ann Oncol; 2011 Nov; 22(11):2533-2534. PubMed ID: 21709139
    [No Abstract]   [Full Text] [Related]  

  • 37. Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.
    Liu J; Liu JF; Wang K; Yan ZL; Wan XY; Huang AM; Wang YZ; Li J; Xia Y; Shi LH; Jiao BH; Zhang Y; Shen F
    Oncol Rep; 2015 Dec; 34(6):3174-86. PubMed ID: 26398566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of MAGE-A9 expression in patients with colorectal cancer.
    Zhan W; Zhang Z; Zhang Y; Ma J; Wu T; Gu Y; Li Y; Yang J
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):239-45. PubMed ID: 26516058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.